The following Fluzone vaccine options will be supplied this season to immunize children as young as 6 months through adults aged ≥65:
- Fluzone High-Dose vaccine: indicated for patients aged ≥65 years
- Fluzone Intradermal Quadrivalent vaccine: indicated for patients aged 18–64 years
- Fluzone Quadrivalent vaccine: indicated for patients ≥6 months
- Fluzone vaccine: indicated for patients ≥6 months
Fluzone Intradermal Quadrivalent vaccine is launching for the first time this influenza season. The vaccine is given intradermally through a 90% smaller, 1.5mm microneedle. The microinjection system has a pre-affixed needle and an integrated needle shield.
Healthcare providers who placed reservations should expect initial shipments to arrive by the end of August.
For more information call (800) 822-2463 or visit Fluzone.com.